Scinai Immunotherapeutics Shares Resumed Trade
Portfolio Pulse from Benzinga Newsdesk
Scinai Immunotherapeutics shares have resumed trading.
July 15, 2024 | 1:48 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Scinai Immunotherapeutics shares have resumed trading, which could lead to increased volatility in the short term.
The resumption of trading in Scinai Immunotherapeutics shares could lead to increased volatility as investors react to the news. The impact on the stock price is uncertain, hence a neutral score.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100